Ipca Laboratories Ltd.

NSE: IPCALAB | BSE: 524494 | ISIN: INE571A01038 | Industry: Pharmaceuticals
| Mid-range Performer
1395.2000 -4.10 (-0.29%)
NSE Sep 23, 2025 15:31 PM
Volume: 202.4K
 

1395.20
-0.29%
ICICI Securities Limited
Revenues grew 5% YoY to | 666 crore (I-direct estimate: | 701 crore) driven by 9% growth in domestic formulations to | 277 crore (I-direct estimate: | 285 crore) and 27% growth in APIs to | 154 crore...
Ipca Laboratories Ltd. has an average target of 1756.67 from 3 brokers.
More from Ipca Laboratories Ltd.
Recommended